BioDr. Bilenker joined Aisling in 2006 and currently serves as an Operating Partner. He is President and Chief Executive Officer of Loxo Oncology, an Aisling Capital III portfolio company. Prior to Aisling, Dr. Bilenker served as a Medical Officer in the Office of Oncology Drug Products at the U.S. Food and Drug Administration for two years. While at the FDA, he conducted clinical reviews of IND-stage and licensed biolo ....
Education
Degrees
Start Free Trial
Access "JOSH BILENKER" Work Experience (Current/Past), Board Seats, Joined Date, Contact Details - Emailid/Phone and Investments (If any) in one connected platform (AcquityData).